248.622.73 Boehringer Ingelheim Investigational Site

San Francisco, California

0 studies enrolling now · 1 studies all time

What they study most

Parkinson Disease

Studies at this site

• A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients — Completed